koryu

editas medicine crispr/cas9 investment

做多
koryu 已更新   
NASDAQ:EDIT   Editas Medicine, Inc.
12
I enter long as long term investment in CRISPR/Cas9 technology.

There is still a patent battle going on, thats why there is the big dump in the chart.

Buying here feels like catching the knife, so buying slowly over time.


交易开始:
nice start. also watching NTLA
评论:
was lucky and got in at 13.40$

There was a bullish divergence on daily rsi. Now watching carefully if it is an additional inv h+s forming. Really like this stock. Ready to increase position if bottom is confirmed.

评论:
increasing position in this dip
评论:
pitchfork scenario
评论:
adjusted pitchfork and channel, fits really good! would be amazing bull market (must break out the channel!) definitly watch this
评论:
break out channel and horizontal resistance! <3
评论:
EW
评论:
bounced on the potential pitchfork and formed a weekly hammer candle which tested the long term downtrend in bullish manner
评论:
HODL the double up :D

免责声明

这些信息和出版物并不意味着也不构成TradingView提供或认可的金融、投资、交易或其它类型的建议或背书。请在使用条款阅读更多信息。